Skip to Content

Bio-Bridge Science Inc BGES

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Bio-Bridge Science Inc is a biotech company focused on the commercial development of biological products for the prevention and treatment of human diseases and manufacturing and sales of materials in producing vaccines. It develop products in respect to HIV vaccine, a vaccine to prevent AIDS; a colon cancer therapeutic vaccine; and an HPV vaccine to prevent cervical cancer.

Contact
PO Box 168081
Chicago, IL, 60616
T +1 630 613-9687
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2011
Fiscal Year End Dec 31, 2011
Stock Type Speculative Growth
Employees 23